Diffuse large B-cell lymphoma (DLBCL) is the most prevalent subtype of non-Hodgkin lymphoma (NHL), characterized by its aggressive nature.
New Treatment Options Extend Survival for Veterans with DLBCL
read more
Advances in Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)
Exposures Increase DLBCL Risks for Veterans, Servicemembers
Exposure to a wide range of chemicals and radiation has long been known to increase the risk of developing diffuse large B-cell lymphoma (DLBCL).
Survival Improving for Most Common Lymphoma Diagnosed in Veterans
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma diagnosed in active-duty servicemembers and veterans. Fortunately, advances in understanding of the disease are leading to more targeted and effective therapies and improved survival rates.
